Availability, Affordability, and Variations in Price of GI Cancer Medicines in Nepal
GI cancer drug access in Nepal is limited by low availability and significant price variation. Intrahospital and interhospital price disparities may influence patients to seek out different prices across institutions to avoid financial toxicity, adding logistical burden. Price regulation, transparency, and local manufacturing are needed to improve equitable access to cancer medicines.
Authors
- Bishal Gyawali (ORCID: https://orcid.org/0000-0001-7444-8594)
- Bishesh Sharma Poudyal (ORCID: https://orcid.org/0000-0001-5896-0379)
- Mukesh Yadav (ORCID: https://orcid.org/0009-0006-8507-1319)
- Nirmal Lamichhane (ORCID: https://orcid.org/0000-0003-0667-6434)
- Bishnu Dutta Paudel (ORCID: https://orcid.org/0000-0002-8817-7585)
- Ramila Shilpakar (ORCID: https://orcid.org/0000-0002-8594-6975)
- Brian Shkabari (ORCID: https://orcid.org/0009-0002-3623-1399)
- Bibek Acharya (ORCID: https://orcid.org/0000-0002-6131-6477)
- Guru Sharan Sah (ORCID: https://orcid.org/0009-0005-1586-3217)
Institutions
- Ontario Institute for Cancer Research (CA)
- Queen's University (CA)
- Bir Hospital (NP)
- B.P. Koirala Memorial Cancer Hospital (NP)
- Nepal Cancer Hospital and Research Center (NP)
- National Academy of Medical Sciences (NP)
- Cancer Care South East (CA)
- Civil Service Hospital (NP)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1200/go-25-00328
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00